Hepatocellular Carcinoma in the Setting of HBV Infection: Risk Assessment, Screening, and Surveillance

Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.
Robert S. Brown, Jr., MD, MPH
Format: Adobe Acrobat (.pdf)
File Size: 88 KB
Released: February 22, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Download free expert-authored slides to get up-to-date on Asia-Pacific considerations regarding HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Clinical Care Options (CCO) expert Dr. Norah Terrault on HCC risk scores to inform personalized HCC surveillance in patients with chronic hepatitis B

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Brief Clinical Care Options (CCO) presentation on EASL guidance for selecting appropriate treatment of HBV infection for pregnant women or patients with bone/renal disease

Francesco Negro, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 11, 2021 Expired: May 10, 2022

Download free slides reviewing key data and EASL guidance on selecting HBV treatment for patients with bone renal disease and pregnant women

Francesco Negro, MD Released: May 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue